Medy-Tox Inc (086900)

KOSDAQ
Currency in KRW
118,800
-1,000(-0.83%)
Closed
086900 Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
118,300119,800
52 wk Range
116,000218,000
Key Statistics
Edit
Bid/Ask
118,700.00 / 118,800.00
Prev. Close
119,800
Open
119,000
Day's Range
118,300-119,800
52 wk Range
116,000-218,000
Volume
26.93K
Average Volume (3m)
59.02K
1-Year Change
-44.87%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
086900 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
210,000
Upside
+76.77%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Medy-Tox Inc Company Profile

Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; and Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method. It also exports its products to approximately 60 countries, including Japan, Brazil, and internationally. Medy-Tox Inc. was founded in 2000 and is headquartered in Cheongju, South Korea.

Employees
721

Compare 086900 to Peers and Sector

Metrics to compare
086900
Peers
Sector
Relationship
P/E Ratio
73.8x−14.6x−0.6x
PEG Ratio
4.900.020.00
Price/Book
1.6x1.7x2.6x
Price / LTM Sales
3.3x2.8x3.1x
Upside (Analyst Target)
72.6%45.2%53.6%
Fair Value Upside
Unlock13.6%8.0%Unlock

Analyst Ratings

5 Buy
1 Hold
1 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 210,000

(+76.77% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1609.25
Dividend Yield
0.93%
Industry Median 0.26%
Annualised payout
1100
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-- / --
Revenue / Forecast
53.90B / 53.90B
EPS Revisions
Last 90 days

FAQ

What Is the Medy-Tox (086900) Stock Price Today?

The Medy-Tox stock price today is 118,800.00

What Stock Exchange Does Medy-Tox Trade On?

Medy-Tox is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Medy-Tox?

The stock symbol for Medy-Tox is "086900."

Does Medy-Tox Pay Dividends? What’s The Current Dividend Yield?

The Medy-Tox dividend yield is 0.93%.

What Is the Medy-Tox Market Cap?

As of today, Medy-Tox market cap is 791.14B.

What is Medy-Tox Earnings Per Share?

The Medy-Tox EPS is 1,609.25.

What Is the Next Medy-Tox Earnings Date?

Medy-Tox will release its next earnings report on 24 Mar 2025.

From a Technical Analysis Perspective, Is 086900 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.